Kukje Pharma Co., Ltd. (KRX:002720)

Kukje Pharma Revenue

Kukje Pharma had revenue of 48.32B KRW in the quarter ending June 30, 2026, with 7.32% growth. This brings the company's total for the last twelve months to 181.27B, up 8.02% year-over-year. In the year 2025, Kukje Pharma had annual revenue of 175.50B with 12.16% growth. That makes Kukje Pharma the 20,367th largest company in the world by revenue and 1,082nd in South Korea.

• Revenue (ttm): 181.27B
• Revenue Growth: +8.02%
• P/S Ratio: 0.40
• Revenue / Employee: 678.90M
• Employees: 267
• Market Cap: 72.58B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceuticals 170.20B 97.0%
• Other 4.95B 2.8%
• Non-Pharmaceutical 338.65M 0.2%

Fiscal year ended Dec 31, 2025 See the full Kukje Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	175.50B	19.03B	12.16%
Dec 31, 2024	156.46B	21.09B	15.58%
Dec 31, 2023	135.37B	8.79B	6.94%
Dec 31, 2022	126.58B	6.84B	5.71%
Dec 31, 2021	119.75B	-10.65B	-8.17%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error